MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.
Gynecol Oncol. 2014 Jun;133(3):568-74. doi: 10.1016/j.ygyno.2014.03.564. Epub 2014 Mar 25.
Gynecol Oncol. 2014.
PMID: 24680769